Results 211 to 220 of about 278,994 (250)

Gram-positive bacterial infection in severe sepsis

Clinical Intensive Care, 2002
They may be involved in the initial insult precipitating an intensive care admission, but are also often acquired as nosocomial pathogens by critically ill patients. Although sepsis in the context of critical illness is a highly complex process often involving polymicrobial infection, 5-8 discussion of Gr am-po sitive sep sis in isolation is not ...
P Hopkins, S Sriskandan
openaire   +1 more source

Therapy of Gram-Positive Bacterial Infections

Veterinary Clinics of North America: Small Animal Practice, 1988
This article considers the important features of gram-positive bacteria that relate to chemotherapy and the clinical pharmacology of the drugs of choice for treating these infections.
openaire   +2 more sources

Serological detection of Gram-positive bacterial infection around prostheses

The Journal of Bone and Joint Surgery. British volume, 2000
Coagulase-negative staphylococci produce an exocellular glycolipid antigen which has potential as a serological marker of infection in bone. The value of this newly detected antigen was investigated by enzyme-linked immunosorbent assay (ELISA) in 15 patients with culture-proven infection of prostheses caused by Gram-positive bacteria.
M, Rafiq, T, Worthington, S E, Tebbs, R B, Treacy, R, Dias, P A, Lambert, T S, Elliott   +6 more
openaire   +2 more sources

Daptomycin Therapy for Invasive Gram-Positive Bacterial Infections in Children

Pediatric Infectious Disease Journal, 2007
Clinical improvement is often delayed among children with invasive infections caused by multidrug resistant Gram-positive bacteria such as methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE) despite use of standard antimicrobial therapy.
Monica I, Ardura, Asunción, Mejías, Kathy S, Katz, Paula, Revell, George H, McCracken, Pablo J, Sánchez   +5 more
openaire   +2 more sources

Glycopeptides and Antibiotics for Gram-positive Bacterial Infections

2016
Glycopeptides, lipopeptides and other antibiotics, such as linezolid and quinupristin/dalfopristin , are exclusively used for the treatment of infections caused by Gram-positive bacteria. Limited information is available about the dosing of these antibiotics in obese patients.
Syed Tabish R. Zaidi, Brett Janson
openaire   +1 more source

Coumarin-modified ruthenium complexes by disrupting bacterial membrane to combat Gram-positive bacterial infection

Dalton Transactions, 2023
Coumarin-modified ruthenium complexes could efficiently disrupt bacterial membrane and cause the death of bacteria.
Hai-Yan Huang, Pei Wang, Wei Deng, Li-Xin Dou, Xiang-Wen Liao, Jin-Tao Wang, Xue-Min Duan, Ru-Jian Yu, Yan-Shi Xiong   +8 more
openaire   +2 more sources

Polysaccharide Conjugate Vaccines for the Prevention of Gram-Positive Bacterial Infections

1996
Among the most problematic Gram-positive bacteria with regard to human pathology are Staphylococcal species including S. aureus and S. epidermidis, Enterococcal species including E. faecalis and E. faecium, and Streptococcus species including S. pneumoniae and Group B Streptococcus, among others.
R, Naso, A, Fattom
openaire   +2 more sources

Neurodegeneration in models of Gram-positive bacterial infections of the central nervous system

Biochemical Society Transactions, 2007
Gram-positive bacterial infections of the central nervous system, such as meningitis, induce an extensive inflammatory response, which in turn may damage neurons. LTA (lipoteichoic acid) is a component of the Gram-positive bacterial cell wall that induces glial inflammatory activation in vitro and in vivo.
J J, Neher, G C, Brown
openaire   +2 more sources

Drosophila MyD88 is required for the response to fungal and Gram-positive bacterial infections

Nature Immunology, 2001
We report here the identification and functional characterization of DmMyD88, a gene encoding the Drosophila homolog of mammalian MyD88. DmMyD88 combines a Toll-IL-1R homology (TIR) domain and a death domain. Overexpression of DmMyD88 was sufficient to induce expression of the antifungal peptide Drosomycin, and induction of Drosomycin was markedly ...
Servane, Tauszig-Delamasure, Hana, Bilak, Maria, Capovilla, Jules A, Hoffmann, Jean-Luc, Imler   +4 more
openaire   +2 more sources

Benefit-Risk Assessment of Linezolid for Serious Gram-Positive Bacterial Infections

Drug Safety, 2008
Linezolid is an oxazolidinone, a new class of antibacterial with a unique mechanism of action, namely inhibition of the formation of a functional 70S initiation complex in the 50S bacterial ribosomal subunit. Linezolid is highly active against multidrug-resistant Gram-positive cocci, including meticillin-resistant Staphylococcus aureus (MRSA ...
Matthew E, Falagas, Konstantinos Z, Vardakas   +1 more
openaire   +2 more sources